Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

<p>FLORHAM PARK, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in November: Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology Conference […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences/">Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>